Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
M Bassetti, E Repetto, E Righi, S Boni… - Journal of …, 2008 - academic.oup.com
Objectives The increased incidence of nosocomial infections by multidrug-resistant
organisms has motivated the re-introduction of colistin in combination with other …
organisms has motivated the re-introduction of colistin in combination with other …
[PDF][PDF] Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
M Bassetti, E Repetto, E Righi, S Boni… - Journal of …, 2008 - researchgate.net
Objectives: The increased incidence of nosocomial infections by multidrug-resistant
organisms has motivated the re-introduction of colistin in combination with other …
organisms has motivated the re-introduction of colistin in combination with other …
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
M Bassetti, E Repetto, E Righi, S Boni… - J Antimicrob …, 2008 - antimicrobe.org
Objectives The increased incidence of nosocomial infections by multidrug-resistant
organisms has motivated the re-introduction of colistin in combination with other …
organisms has motivated the re-introduction of colistin in combination with other …
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
M Bassetti, E Repetto, E Righi… - The Journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
Objectives The increased incidence of nosocomial infections by multidrug-resistant
organisms has motivated the re-introduction of colistin in combination with other …
organisms has motivated the re-introduction of colistin in combination with other …
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
M Bassetti, E Repetto, E Righi, S Boni… - Journal of Antimicrobial …, 2008 - elibrary.ru
Objectives The increased incidence of nosocomial infections by multidrug-resistant
organisms has motivated the re-introduction of colistin in combination with other …
organisms has motivated the re-introduction of colistin in combination with other …
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
M Bassetti, E Repetto, E Righi, S Boni… - J Antimicrob …, 2008 - antimicrobe.org
Objectives The increased incidence of nosocomial infections by multidrug-resistant
organisms has motivated the re-introduction of colistin in combination with other …
organisms has motivated the re-introduction of colistin in combination with other …
[引用][C] Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
M Bassetti, E Repetto, E Righi, S Boni… - JOURNAL OF …, 2008 - iris.univr.it
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
M Bassetti, E Repetto, E Righi, S Boni, M Diverio… - 2008 - cabidigitallibrary.org
Objectives: The increased incidence of nosocomial infections by multidrug-resistant
organisms has motivated the re-introduction of colistin in combination with other …
organisms has motivated the re-introduction of colistin in combination with other …
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
M Bassetti, E Repetto, E Righi, S Boni… - Journal of …, 2008 - search.ebscohost.com
Objectives The increased incidence of nosocomial infections by multidrug-resistant
organisms has motivated the re-introduction of colistin in combination with other …
organisms has motivated the re-introduction of colistin in combination with other …
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
M Bassetti, E Repetto, E Righi, S Boni… - The Journal of …, 2008 - europepmc.org
Objectives The increased incidence of nosocomial infections by multidrug-resistant
organisms has motivated the re-introduction of colistin in combination with other …
organisms has motivated the re-introduction of colistin in combination with other …